warnings
WARNINGS CONCENTRATED ANTICOAGULANT – DILUTE PRIOR TO USE.
triCitrasol
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- triCitrasol
- Generic name
- TRISODIUM CITRATE DIHYDRATE
- Manufacturer
- Citra Labs LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 64e7652c-1437-43bd-8ea2-3cafab447b8c
- SPL ID
- 49d76384-a8fa-44ed-99b4-1f75ee4a435d
- Version
- 5
- Effective date
- 2023-02-14
- Source export date
- 2026-09-28
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:43:23
| Harmonized routes |
|---|
| EXTRACORPOREAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | BN010409 | openfda.application_number | |
| brand name | triCitrasol | openfda.brand_name | |
| generic name | TRISODIUM CITRATE DIHYDRATE | openfda.generic_name | |
| manufacturer name | Citra Labs LLC | openfda.manufacturer_name | |
| ndc | package | 23731-6030-3 | openfda.package_ndc |
| ndc | package | 23731-6030-1 | openfda.package_ndc |
| ndc | package | 23731-6030-2 | openfda.package_ndc |
| ndc | product | 23731-6030 | openfda.product_ndc |
| ndc11 | package | 23731603003 | derived:openfda.package_ndc |
| ndc11 | package | 23731603002 | derived:openfda.package_ndc |
| ndc11 | package | 23731603001 | derived:openfda.package_ndc |
| spl id | 49d76384-a8fa-44ed-99b4-1f75ee4a435d | id | |
| spl set id | 64e7652c-1437-43bd-8ea2-3cafab447b8c | set_id | |
| unii | B22547B95K | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS Citrate reactions or toxicity may occur with the infusion of blood products containing citrate anticoagulant 1. 9 11 . The recipient of the citrated blood product should be monitored for the signs and symptoms of citrate toxicity 1. 9 11 . The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by chills, stomach cramps, or pressure in the chest, followed by more severe reactions that are characterized by hypotension and possible cardiac arrhythmia 1. 9 11 . Citrate toxicity may occur more frequently in patients that are hypothermic 10 , have impaired liver or renal function 10 , or have low calcium levels because of an underlying disease 9 .
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.